Comparison of Adjuvant Hypertonic Saline and Normal Saline for Epidural Block in Patients with Postherpetic Neuralgia: A Double-Blind, Randomized Trial

• Published in: Pain Research and Management Vol. 2022; pp. 8081443 - 9
• Main Authors: Kwon, Hyun-Jung, Kim, Doo-Hwan, Cho, Seong-Sik, Jeon, Bokyoung, Karm, Myong-Hwan, Choi, Seong-Soo
• Format: Journal Article
• Language: English
• Published: United States Hindawi 21.11.2022; John Wiley & Sons, Inc; Hindawi Limited
• Subjects: Adjuvants; Adjuvants, Pharmaceutic; Analgesics; Anesthesia, Epidural; Anticonvulsants; Care and treatment; Clinical trials; Comparative analysis; Complications and side effects; Double-blind studies; Epidural; Humans; Medical research; Medicine, Experimental; Neuralgia; Neuralgia, Postherpetic - drug therapy; Neuralgia, Postherpetic - etiology; Pain; Patient satisfaction; Saline Solution; Shingles (Disease); Spinal cord; Steroids; South Korea
• ISSN: 1203-6765; 1918-1523
• DOI: 10.1155/2022/8081443

Background. In patients with postherpetic neuralgia (PHN), the effectiveness of epidural block and the benefits of adjuvant hypertonic saline (HS) have not been fully determined. Therefore, we investigated these issues in this study. Methods. At a tertiary medical center’s single pain clinic in Seoul, Republic of Korea, patients complaining of PHN even after 4 months of herpes zoster onset were enrolled and randomly assigned to either the HS or normal saline (NS) group. After epidural block with adjuvant HS or NS administration according to each protocol, outcomes were assessed at baseline and one and three months after the intervention. The primary outcome was pain intensity on the numerical rating scale (NRS). The secondary outcomes were the insomnia severity index (ISI), the medication quantification scale (MQS), and the global perceived effect of satisfaction (GPES). Results. Thirty-six patients (NS: 17, HS: 19) were included in the intention-to-treat analysis. The estimated pain intensity decreased in both groups at one and three months after the procedure (P < 0.001), without a significant group difference. The estimated ISI and MQS were not significantly different at 1 month compared with baseline but significantly decreased at 3 months in each group (P < 0.001 and P < 0.001, respectively), without group differences. In addition, there was no difference between the groups on the GPES scale at one and three months after the procedure. Conclusions. Epidural steroid injection may have the advantages of short-term pain relief, improved sleep quality, and decreased medication usage in patients with PHN. In addition, adjuvant HS administration with epidural steroid injection did not show beneficial effects in patients with PHN. Further studies are needed to clarify the potential effectiveness of HS in treating neuropathic pain such as PHN. This trial is registered with KCT0002845.